{"id":"https://openalex.org/W2084066254","doi":"https://doi.org/10.1055/s-2008-1076191","title":"Verbesserung von Betazellfunktion und glyk\u00e4mischer Kontrolle nach einem Jahr Therapie mit Exenatide bei Metformin-behandelten Patienten mit Typ-2-Diabetes","display_name":"Verbesserung von Betazellfunktion und glyk\u00e4mischer Kontrolle nach einem Jahr Therapie mit Exenatide bei Metformin-behandelten Patienten mit Typ-2-Diabetes","alternate_titles":[],"publication_year":2008,"publication_date":"2008-01-01","ids":{"openalex":"https://openalex.org/W2084066254","doi":"https://doi.org/10.1055/s-2008-1076191","mag":"2084066254"},"language":"de","primary_location":{"id":"doi:10.1055/s-2008-1076191","doi":"https://doi.org/10.1055/s-2008-1076191","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2008-1076191","pdf_url":null,"source":{"id":"https://openalex.org/S26605106","display_name":"Diabetologie und Stoffwechsel","issn_l":"1861-9002","issn":["1861-9002","1861-9010"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321135","host_organization_name":"Georg Thieme Verlag","host_organization_lineage":["https://openalex.org/P4310321135","https://openalex.org/P4310320000"],"host_organization_lineage_names":["Georg Thieme Verlag","Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologie und Stoffwechsel","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2084066254"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5070186988","display_name":"Oliver P. Bachmann","orcid":"https://orcid.org/0000-0002-6830-2975","observed_orcids":["https://orcid.org/0000-0002-6830-2975"]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"O Bachmann","raw_affiliation_strings":["On behalf of the Original Research Group: Lilly Deutschland GmbH, Bad Homburg, Deutschland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"On behalf of the Original Research Group: Lilly Deutschland GmbH, Bad Homburg, Deutschland","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5085855526","display_name":"CHRISTOF M. KAZDA","orcid":"https://orcid.org/0000-0002-2538-2573","observed_orcids":["https://orcid.org/0000-0002-2538-2573"]},"institutions":[{"id":"https://openalex.org/I4210110958","display_name":"Eli Lilly (Germany)","ror":"https://ror.org/01pmvz131","country_code":"DE","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210110958"]}],"countries":["DE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C Kazda","raw_affiliation_strings":["On behalf of the Original Research Group: Lilly Deutschland GmbH, Bad Homburg, Deutschland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"On behalf of the Original Research Group: Lilly Deutschland GmbH, Bad Homburg, Deutschland","institution_ids":["https://openalex.org/I4210110958"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5083744147","display_name":"M C M Bunck","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MC Bunck","raw_affiliation_strings":["VU University Medical Center, Department of Endocrinology, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU University Medical Center, Department of Endocrinology, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109335776","display_name":"Micha\u00ebla Diamant","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"M Diamant","raw_affiliation_strings":["VU University Medical Center, Department of Endocrinology, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU University Medical Center, Department of Endocrinology, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I911458345"]}]},{"author_position":"middle","author":{"id":null,"display_name":"A Corn\u00e9r","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"A Corn\u00e9r","raw_affiliation_strings":["Helsinki University Hospital, Department of Medicine, Helsinki, Finnland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helsinki University Hospital, Department of Medicine, Helsinki, Finnland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061198575","display_name":"Bj\u00f6rn Eliasson","orcid":"https://orcid.org/0000-0003-2569-4160","observed_orcids":["https://orcid.org/0000-0003-2569-4160"]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B Eliasson","raw_affiliation_strings":["Sahlgrenska University Hospital, Lundberg Laboratory for Diabetes Research, Goteborg, Schweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sahlgrenska University Hospital, Lundberg Laboratory for Diabetes Research, Goteborg, Schweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004842224","display_name":"Jaret L. Malloy","orcid":"https://orcid.org/0000-0001-6937-9854","observed_orcids":["https://orcid.org/0000-0001-6937-9854"]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"J Malloy","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111844527","display_name":"R.M. Shaginian","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210123112","display_name":"Eli Lilly (Netherlands)","ror":"https://ror.org/02ve0bg52","country_code":"NL","type":"company","lineage":["https://openalex.org/I168537998","https://openalex.org/I4210123112"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"RM Shaginian","raw_affiliation_strings":["Eli Lilly and Company, Houten, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Eli Lilly and Company, Houten, Niederlande","institution_ids":["https://openalex.org/I4210123112"]}]},{"author_position":"middle","author":{"id":null,"display_name":"W Deng","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"W Deng","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110164292","display_name":"DM Kendall","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"DM Kendall","raw_affiliation_strings":["Amylin Pharmaceuticals, Inc., San Diego, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Amylin Pharmaceuticals, Inc., San Diego, USA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5057557099","display_name":"Marja\u2010Riitta Taskinen","orcid":"https://orcid.org/0000-0002-6229-3588","observed_orcids":["https://orcid.org/0000-0002-6229-3588"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"MR Taskinen","raw_affiliation_strings":["Helsinki University Hospital, Department of Medicine, Helsinki, Finnland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helsinki University Hospital, Department of Medicine, Helsinki, Finnland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028599620","display_name":"Ulf Smith","orcid":"https://orcid.org/0000-0002-1439-4608","observed_orcids":["https://orcid.org/0000-0002-1439-4608"]},"institutions":[{"id":"https://openalex.org/I2801112325","display_name":"Sahlgrenska University Hospital","ror":"https://ror.org/04vgqjj36","country_code":"SE","type":"healthcare","lineage":["https://openalex.org/I2801112325"]}],"countries":["SE"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"U Smith","raw_affiliation_strings":["Sahlgrenska University Hospital, Lundberg Laboratory for Diabetes Research, Goteborg, Schweden"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sahlgrenska University Hospital, Lundberg Laboratory for Diabetes Research, Goteborg, Schweden","institution_ids":["https://openalex.org/I2801112325"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028953583","display_name":"Hannele Yki\u2010J\u00e4rvinen","orcid":"https://orcid.org/0000-0001-6766-1549","observed_orcids":["https://orcid.org/0000-0001-6766-1549"]},"institutions":[{"id":"https://openalex.org/I2800394112","display_name":"Helsinki University Hospital","ror":"https://ror.org/02e8hzf44","country_code":"FI","type":"healthcare","lineage":["https://openalex.org/I2800394112","https://openalex.org/I4210166427"]}],"countries":["FI"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"H Yki-Jarvinen","raw_affiliation_strings":["Helsinki University Hospital, Department of Medicine, Helsinki, Finnland"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Helsinki University Hospital, Department of Medicine, Helsinki, Finnland","institution_ids":["https://openalex.org/I2800394112"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5113467761","display_name":"Robert J. Heine","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I911458345","display_name":"Amsterdam UMC Location Vrije Universiteit Amsterdam","ror":"https://ror.org/00q6h8f30","country_code":"NL","type":"healthcare","lineage":["https://openalex.org/I4210151833","https://openalex.org/I911458345"]}],"countries":["NL"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"RJ Heine","raw_affiliation_strings":["VU University Medical Center, Department of Endocrinology, Amsterdam, Niederlande"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"VU University Medical Center, Department of Endocrinology, Amsterdam, Niederlande","institution_ids":["https://openalex.org/I911458345"]}]}],"institutions":[],"countries_distinct_count":4,"institutions_distinct_count":5,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":0.0,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":{"value":0.0,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"3","issue":"S 1","first_page":null,"last_page":null},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10401","display_name":"Diabetes Treatment and Management","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10839","display_name":"Pancreatic function and diabetes","score":0.000699999975040555,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10560","display_name":"Diabetes Management and Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2712","display_name":"Endocrinology, Diabetes and Metabolism"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/exenatide","display_name":"exenatide","score":0.9869999885559082},{"id":"https://openalex.org/keywords/type-2-diabetes","display_name":"type 2 diabetes","score":0.7900000214576721},{"id":"https://openalex.org/keywords/beta-cell-function","display_name":"beta-cell function","score":0.7900000214576721},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.7160000205039978},{"id":"https://openalex.org/keywords/insulin-glargine","display_name":"insulin glargine","score":0.9710000157356262},{"id":"https://openalex.org/keywords/c-peptide-secretion","display_name":"C-peptide secretion","score":0.7620000243186951},{"id":"https://openalex.org/keywords/arginine-stimulation","display_name":"arginine stimulation","score":0.8949999809265137},{"id":"https://openalex.org/keywords/glycemic-control","display_name":"glycemic control","score":0.7570000290870667},{"id":"https://openalex.org/keywords/hba1c","display_name":"HbA1c","score":0.8420000076293945},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.46799999475479126},{"id":"https://openalex.org/keywords/incretin-based-therapy","display_name":"incretin-based therapy","score":0.8059999942779541},{"id":"https://openalex.org/keywords/weight-gain","display_name":"weight gain","score":0.3630000054836273},{"id":"https://openalex.org/keywords/drug-safety","display_name":"drug safety","score":0.39800000190734863},{"id":"https://openalex.org/keywords/hyperinsulinemic-euglycemic-clamp","display_name":"hyperinsulinemic-euglycemic clamp","score":0.7680000066757202},{"id":"https://openalex.org/keywords/hyperglycemic-clamp","display_name":"hyperglycemic clamp","score":0.8989999890327454},{"id":"https://openalex.org/keywords/first-phase-insulin-secretion","display_name":"first-phase insulin secretion","score":0.41600000858306885}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8625122308731079},{"id":"https://openalex.org/C2780533449","wikidata":"https://www.wikidata.org/wiki/Q417762","display_name":"Exenatide","level":4,"score":0.8506478071212769},{"id":"https://openalex.org/C29456083","wikidata":"https://www.wikidata.org/wiki/Q1221899","display_name":"Gynecology","level":1,"score":0.5474799275398254},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5037230849266052},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.20817267894744873},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.16243308782577515},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.15199705958366394},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.14114516973495483},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.13747477531433105}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1055/s-2008-1076191","doi":"https://doi.org/10.1055/s-2008-1076191","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-2008-1076191","pdf_url":null,"source":{"id":"https://openalex.org/S26605106","display_name":"Diabetologie und Stoffwechsel","issn_l":"1861-9002","issn":["1861-9002","1861-9010"],"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":["poland-20","russia-white-list-3"],"host_organization":"https://openalex.org/P4310321135","host_organization_name":"Georg Thieme Verlag","host_organization_lineage":["https://openalex.org/P4310321135","https://openalex.org/P4310320000"],"host_organization_lineage_names":["Georg Thieme Verlag","Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Diabetologie und Stoffwechsel","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being","score":0.98580002784729}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2148798434","https://openalex.org/W2092936519","https://openalex.org/W1980288013","https://openalex.org/W2486351957","https://openalex.org/W2029228033","https://openalex.org/W2036806748","https://openalex.org/W1923756566","https://openalex.org/W1980543938"],"abstract_inverted_index":{"Fragestellung:":[0],"Bei":[1],"den":[2,36,126],"meisten":[3],"Patienten":[4,68,166,368],"sind":[5],"klassische":[6],"Therapien":[7],"zur":[8,137,196,362],"Blutzucker-Senkung":[9],"nicht":[10],"ausreichend":[11],"f\u00fcr":[12,92],"einen":[13],"langfristigen":[14],"Erhalt":[15],"der":[16,117,147,164,176,184,206,307,318,341],"glyk\u00e4mischen":[17],"Kontrolle.":[18,359],"Das":[19],"Inkretinmimetikum":[20],"Exenatide":[21,43,87,198,214,226,244,264,276,327,337,360],"f\u00fchrte":[22,277,361],"in":[23,125,175,183,257],"pr\u00e4klinischen":[24],"und":[25,56,103,144,156,265,346],"klinischen":[26],"Studien":[27],"zu":[28,280,283],"einer":[29,160,284],"verbesserten":[30],"Betazellfunktion.":[31],"Diese":[32],"klinische":[33],"Studie":[34],"verglich":[35],"Effekt":[37],"von":[38],"einem":[39,172,210,254,333],"Jahr":[40,173,211,255,334],"Therapie":[41,335],"mit":[42,69,98,213,218,261,303,336],"vs.":[44,200,228,246,288,329],"Insulin":[45,108,281,352],"Glargin":[46,109,201,219,229,247,282,323,353,365],"auf":[47,86],"die":[48,120,142,168,344,367],"Betazellfunktion,":[49,342],"gemessen":[50],"unter":[51,263,267,322,326,364],"euglyk\u00e4mischem/hyperinsulin\u00e4mischem":[52],"Clamp":[53,59],"(5":[54],"mM)":[55,61],"anschlie\u00dfendem":[57],"hyperglyk\u00e4mischen":[58],"(15":[60],"bei":[62,132,162,356],"zus\u00e4tzlicher":[63],"Arginin-Stimulation.":[64],"Methodik:":[65],"68":[66,165],"Metformin-behandelte":[67],"Typ-2-Diabetes":[70],"(Mittelwert\u00b1STD:":[71],"Alter":[72],"59\u00b18":[73],"Jahre;":[74],"HbA":[75,99,152,250],"1c":[76,100,153,251],"7,5\u00b10,8%;":[77],"BMI":[78],"31\u00b14kg/m":[79],"2":[80],";":[81],"Gewicht":[82,155],"91,5\u00b113,1kg)":[83],"wurden":[84],"randomisiert":[85],"(n=36;":[88],"5\u00b5?":[89],"g":[90],"BID":[91,97],"4":[93],"Wo.,":[94],"dann":[95],"10\u00b5g":[96],"-Ziel":[101],"\u22647%":[102],"Maximaldosis":[104],"20\u00b5g":[105],"TID)":[106],"oder":[107],"(n=32;":[110],"Therapieziel":[111],"N\u00fcchternglucose":[112],"[FPG]":[113],"<5.6":[114],"mmol/L).":[115],"Ma\u00df":[116],"Betazellfunktion":[118],"war":[119,167,212,234,256,301],"Glucose(15":[121],"mM)-potenzierte,":[122],"Arginin-stimulierte":[123,169],"C-Peptid-Sekretion":[124,148,170,208],"ersten":[127],"10":[128],"Min":[129],"nach":[130,149,171,209,253],"Argininin-Bolus":[131],"Woche":[133],"52":[134],"im":[135,278,349],"Verh\u00e4ltnis":[136,195],"Baseline.":[138],"Weitere":[139],"Endpunkte":[140],"waren":[141,321,338],"erste":[143,204],"zweite":[145,232],"Phase":[146,205,233],"i.v.":[150],"Glucose,":[151],",":[154],"Vertr\u00e4glichkeit.":[157],"Ergebnisse:":[158],"In":[159],"Interimanalyse":[161],"48":[163],"Behandlung":[174],"Exenatide-Gruppe":[177],"(n=26)":[178],"um":[179,235],"125%":[180],"gr\u00f6\u00dfer":[181],"als":[182,194,217,325],"Glargin-Gruppe":[185],"(n=22)":[186],"(95%":[187,220,238],"KI":[188,221,239],"0,91":[189],"bis":[190,223,241,273,294,313],"1,64;":[191],"p<0,0001;":[192,243],"Mittelwerte\u00b1SEM":[193],"Baseline:":[197],"2,45\u00b10,16":[199],"1,15\u00b10,06).":[202],"Die":[203,231,249,297],"Glucose-induzierten":[207],"52%":[215],"h\u00f6her":[216,237],"0,27":[222],"0,80;":[224],"p<0;0001;":[225],"1,76\u00b10,12":[227],"1,21\u00b10,09).":[230],"175%":[236],"1,31":[240],"2,28;":[242],"2,94\u00b10,21":[245],"1,14\u00b10,06).":[248],"-Senkung":[252],"beiden":[258],"Gruppen":[259],"vergleichbar,":[260],"-0,77\u00b10,13%":[262],"-0,94\u00b10,17%":[266],"Glargin;":[268],"0,29%":[269],"Unterschied":[270],"(95%KI":[271],"-0,09%":[272],"+0,66%;":[274],"p=0,13).":[275],"Vergleich":[279,350],"signifikanten":[285],"Gewichtsabnahme":[286],"(-3,88\u00b10,8kg":[287],"+1,4\u00b11,1kg;":[289],"Differenz":[290],"-5,2kg;":[291],"95%KI":[292],"-8,0":[293],"-2,4kg;":[295],"p=0,0005).":[296],"H\u00e4ufigkeit":[298],"unerw\u00fcnschter":[299],"Ereignisse":[300],"vergleichbar":[302],"fr\u00fcheren":[304],"Exenatide-Studien:":[305],"17":[306],"36":[308],"(47%)":[309],"Exenatide-Patienten":[310],"hatten":[311],"leichte":[312],"moderate":[314],"\u00dcbelkeit,":[315],"aber":[316],"keiner":[317],"Glargin-Patienten.":[319],"Hypoglyk\u00e4mien":[320],"h\u00e4ufiger":[324],"(25%":[328],"14%).":[330],"Schlussfolgerungen:":[331],"Nach":[332],"mehrere":[339],"Indices":[340],"u.a.":[343],"Glucose-":[345],"Arginin-induzierte":[347],"Insulinsekretion,":[348],"zum":[351],"deutlich":[354],"verbessert,":[355],"vergleichbarer":[357],"glyk\u00e4mischer":[358],"Gewichtsreduktion,":[363],"nahmen":[366],"zu.":[369]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2084066254","counts_by_year":[],"updated_date":"2026-11-14T11:04:58.165337","created_date":"2016-06-24T00:00:00"}
